Healthcare CDMO Market Share

Statistics for the 2023 & 2024 Healthcare CDMO market share, created by Mordor Intelligence™ Industry Reports. Healthcare CDMO share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Healthcare CDMO Industry

The healthcare contract development and manufacturing organization market is fragmented in nature, with the presence of many market players anticipated to concentrate on offering one-stop-shop services to gain a competitive edge. Moreover, market players are engaging in strategic activities such as service expansion, collaboration, partnerships, and mergers and acquisitions. 

Some of the key players in the healthcare CDMO market are Catalent Inc., Lonza, Recipharm AB, Thermo Fisher Scientific, Inc., Labcorp Drug Development, and IQVIA Inc.

Healthcare CDMO Market Leaders

  1. Catalent Inc.

  2. Lonza

  3. Recipharm AB

  4. Thermo Fisher Scientific, Inc

  5. Labcorp Drug Development

*Disclaimer: Major Players sorted in no particular order

Healthcare CDMO Market Concentration

Healthcare Contract Development and Manufacturing Organization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)